CXCL16 and Hepatic fibrosis: Consistent with the in vitro results, QGHXR intervention robustly decreased CXCL16 levels in the serum and liver of ethanol-fed mice injected with CCl4, indicating that the reduced CXCL16 level is partially attributed to QGHXR-induced protective effects in experimental liver fibrosis.